In vivo efficacy of SM-8668 (Sch 39304), a new oral triazole antifungal agent.
SM-8668 (Sch 39304) is a new oral antifungal agent which we evaluated in comparison with fluconazole in various fungal infection models. The prophylactic effect of SM-8668 was excellent against systemic candidiasis, aspergillosis, and cryptococcosis in mice. The 50% effective dose for SM-8668 was as...
-д хадгалсан:
| -д хэвлэсэн: | Antimicrob Agents Chemother |
|---|---|
| Үндсэн зохиолчид: | , , , |
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
American Society for Microbiology (ASM)
1990
|
| Нөхцлүүд: | |
| Онлайн хандалт: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171742/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2203310/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.6.980 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
